A randomized clinical trial in Ireland reports that 0.01% atropine eye drops stabilize macular choroidal thickness over two years, offering clinicians new insights into how low-dose atropine may influence...
In England, children and young people faced sharply higher risks of venous thromboembolism, thrombocytopenia, myocarditis or pericarditis, and systemic inflammatory conditions after a first COVID-19...
A large, community-based randomized trial found that once-daily, full-body emollient use beginning in early infancy reduced the risk of developing atopic dermatitis by age 2. The protective effect was...
This FDA Roundup includes an at-a-glance look at the latest FDA drug approvals in June and July, including the first over-the-counter, nonprescription daily oral contraceptive, the first monoclonal...
European countries with more restrictive reimbursement for growth hormone use in pediatric end-stage renal disease end up with shorter children, according to a new report.
